Scientists scan brains to see if cancer drugs cause 'Chemo Brain'
NCT ID NCT03016741
Summary
This study aims to understand if two common prostate cancer drugs, abiraterone and enzalutamide, affect memory, concentration, and other thinking skills. Researchers will use brain scans and cognitive tests to compare 100 men with advanced prostate cancer who are taking these drugs. The goal is to learn if these treatments cause changes in brain function and identify which patients might be more at risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Los Angeles, California, 91010, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Tulane Cancer Center
New Orleans, Louisiana, 70112, United States
-
University of Minnesota: Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.